Other gene alterations, e.g. Fibroblast growth factor receptor 1 (FGFR1) amplification (20%) and anaplastic lymphoma kinase (ALK) rearrangement (3–7%) are also found in NSCLC [6–8]. The gene discussed is FGFR1; the disease is non-small cell lung carcinoma.